We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 16 investment: Withheld
Riders can enjoy indoor cycling within a boutique fitness studio. In the past 6 years, Boom Cycle have opened five sites are now seeking funds to expand their portfolio. To date, Boom Cycle has acquired over £4.1m from private investors and in 2017 spent £2.1m on developing two flagship studios. The company has experienced attendance growth of 47% YoY, as well as a 77% increase in revenue YoY.
days to go: Expired investment: £805,260
Endurance Sports TV (ESTV) is a portal that focuses on events like live racing, race reports, athlete biographies and documentaries. It aims to deliver engaging high-quality content via a Subscription-Video-On-Demand (SVOD) service available via web, mobile and TV mediums (Apple, Android, Firestick, Roku and Chromecast). ESTV has 81 million endurance sports fans and participants globally. The company’s app has seen more than 5000 downloads in over 100 countries. The platform also offers advertisement-free curated viewing to its viewers. ESTV has curated over 600 sports videos since 2019. The company will use the investment to focus on making video content broadcasting special features with global sports talent and covering top events. It will also use its PR & marketing teams to reach out to sports journalists and utilise social media channels to connect with fans and participants everywhere.

Pitch Rated

87%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £82,220
BioSure HIV Self Test allows for private testing in a time and place convenient to the user. The test is discreetly delivered in the post and once everything is finished all the testing equipment can be thrown away in the bag provided with the usual rubbish. 
days to go: Expired investment: £495,459
1854 Media is a multi-award-winning media brand powered by a global community of 2m+ creatives including many influential creators, media & arts institutions. It has been designed to discover and showcase the most talented, established, and emerging photographers, helping brands create imagery that cuts through the noise of 3 billion photos taken daily. Its exhibitions are seen by tens of millions with 90,000+ paid image entries. The company's mission is to become an essential platform for photographers by providing the vital tools they need to succeed. 1854 Media has 70% recurring customers since the last raise, and the company is now raising capital to accelerate growth.
days to go: Expired investment: £379,280
Chew is a live streaming community built for DJ's. Chew allows DJ's to share their mixes and help them to build a worldwide fan base.
days to go: Expired investment: £215,019
Unbound disrupts traditional publishing through a crowdfunding model, empowering readers to support authors' creativity while fostering a digital community. Their unique approach allows the publishing of diverse, creative, and daring works, providing readers with exclusive experiences not found in conventional bookshops. With a rapidly growing market since the pandemic, Unbound engages thousands of supporters worldwide, offering exclusive content like podcasts and newsletters, reaching over 340,000 readers globally, alongside broader sales in bookshops and online platforms. They also hold licenses to publish and distribute books, exploring potential film and TV opportunities based on authors' rights.
days to go: Expired investment: £168,038
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph